Mutations in the gene of the G protein-coupled vasopressin V 2 receptor (V 2 receptor) cause Xlinked nephrogenic diabetes insipidus (NDI). Most of the missense mutations on the extracellular face of the receptor introduce additional cysteine residues. Several groups have proposed that these residues might disrupt the conserved disulfide bond of the V 2 receptor. To test this hypothesis, we first calculated a structure model of the extracellular receptor domains.
INTRODUCTION
The vasopressin V 2 receptor (V 2 receptor) 1 only few mutations are located on the cytoplasmic or extracellular faces of the receptor. It is striking that most of the extracellular mutations introduce additional cysteine residues. Such mutations include R106C (3), R181C (4, 5) , G185C (6), R202C (6, 3, 7) and Y205C (6, 8, 9) .
The most obvious explanation for the origin of the defect caused by these additional extracellular cysteine residues is that they impair formation of the single disulfide bond of the V 2 receptor which connects residue C112 of the first with C192 of the second extracellular loop and which is conserved in the GPCR family. Several groups have proposed that the mutated residues form an alternative bond with either one of the two conserved cysteine by guest on October 30, 2017
http://www.jbc.org/ Downloaded from 4 residues (6, 5, 9, 10) . Disease causing mutations which lead to the introduction of additional cysteine residues have been observed for other GPCR's. The Y178C mutation of rhodopsin was shown to cause retinitis pigmentosa and is suspected to impair the formation of the conserved disulfide bond of this receptor (11) . The analysis of the molecular basis of the defect caused by these "additional C" mutations of GPCR's is thus of general interest.
In the case of the V 2 receptor, recent studies called into question whether the additional cysteine residues impaired formation of the conserved disulfide bond (12) : mutation of the conserved cysteine residues led to nonfunctional receptors whith a strong transport defect, whereas the NDI-causing mutations G185C and R202C led to binding-defective but transport competent receptors. If the additional cysteines of the NDI-causing mutant receptors were to disrupt the conserved disulfide bond, an impaired intracellular transport of these mutant receptors would also have been expected.
Here we have analyzed the defects of the NDI-causing mutant receptors G185C and R202C in detail. We present molecular modelling and mutagenesis data which strongly suggest that the additional cysteine residues of both mutant receptors participate in a second disulfide bond with residue C195 of the V 2 receptor rather than impairing formation of the conserved bond. Visualization of GFP-tagged receptors by confocal laser scanning microscopy.
Transiently transfected HEK 293 cells expressing the GFP-tagged receptors were grown on glass coverslips. Cells were washed twice with PBS (pH 7.4), transferred immediately into a self-made chamber (details on request) and covered with 1 ml PBS (pH 7.4). The GFP fluorescence signals were visualized on a Zeiss 410 invert laser scanning microscope (λ exc = 488 nm, λ em = >515 nm). Subsequently, the cell surface of the same cells was stained with 0.05% trypan blue as described (15) . Trypan blue fluorescence (λ exc = 543 nm, λ em = >590 nm) was recorded on a second channel and its overlap with the GFP signals was computed.
V 2 receptor model building.
A structure model of the transmembrane and the intracellular domains of the V 2 receptor was described previously (13) . For this model, packing of the transmembrane helices was based on electron density maps of frog rhodopsin (18) .
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The structure model of the extracellular domains was assembled stepwise taking this and with its C-terminal portion in the smaller cavity formed by TM2, TM3, TM7 and parts of ECL1, ECL2 and ECL3 (20) . Similar structure models for the location of the ligand binding domain have been proposed for other GPCR's with peptide ligands (21) . Our model predicts that the entrance of the larger ligand binding cavity is surrounded by the long ECL2 domain which forms a U-like loop (see Fig. 2A ). Residue C195 would be located in the centre of the extracellular face of the receptor at the tip of the U-like loop and, more importantly, would be 11 accessible to each of the cysteine residues introduced by the NDI-causing mutations. Our model thus raises the possibility that the additional cysteine residues form a second disulfide bond with residue C195 rather than disrupting the conserved bond between C112 and C192.
This second bond may be formed easily in the case of our previously described mutant receptors G185C and R202C (12) , since their additional cysteine residues lie at the surface of the molecule at approximately the same level as residue C195 (see Fig. 2B ). Formation of the putative second disulfide bond could cause sealing of the entrance of the larger ligand binding cavity and/or may pertubate this site at a deeper level (see Fig. 2A ). In either case, the newly formed disulfide bond should not have a major influence on the overall structure of the receptor.
A C195A mutation suppresses the defect of the NDI-causing mutations G185C and R202C. To address the question of whether or not second disulfide bonds are formed upon introduction of the additional extracellular cysteine residues, we have introduced a C195A mutation into our previously described GFP-tagged NDI-causing receptor mutants G185C.GFP and R202C.GFP (12) For the cell surface biotinylation assay, (Fig. 6B) , plasma membrane proteins of intact cells were labelled with biotin. Biotinylated proteins were isolated with neutravidin and subjected to SDS-PAGE. The receptors were detected on immunoblots using an anti-GFP antiserum.
Complex glycosylated 75-80 kDa forms were detectable for WT.GFP and both double 15 mutants, but not in the case of the transport deficient mutant ∆L62-R64.GFP. For WT.GFP and both double mutants, additional faint 60 kDa protein bands were observed. This protein band seems to represent degradation products of the complex glycosylated forms. It was not observed for mutant ∆L62-R64.GFP, demonstrating that it does not represent high mannose forms (which might have become labeled e.g. due to cell lysis). The amount of the complex glycosylated forms of double mutant R202C/C195A.GFP was comparable to that of WT.GFP and the double mutant G185C/C195A.GFP. These results thus show that the decreased B max of R202C/C195A.GFP did not result from a decreased transport level, again consistent with the LSM localization study.
In summary, despite the fact that the molecular basis of the decreased B max of R202C/C195A.GFP remains elusive, our results clearly show that the NDI-causing mutant receptors G185C and R202C can be functionally rescued by an additional C195A mutation.
They thus strongly suggest that the second disulfide bond predicted by the structure model is indeed formed in the mutant receptors.
The free extracellular cysteine residue C195 of the V 2 receptor is not conserved throughout evolution. It was previously shown that residue C195 is not essential for V 2 receptor function (22) . Our results demonstrate that this residue might even be disadvantageous if additional cysteine residues are introduced by a mutation. We therefore examined whether residue C195 is conserved throughout evolution. An alignment of the second extracellular loops of the V 2 receptors of various species shows that this residue is not conserved among mammals (Fig. 7A) . Most mammals have a basic arginine or histidine residue at this position, which protect them from damage caused by mutationally introduced extracellular cysteine residues. We then determined the approximate time point in evolution when this residue was introduced into the V 2 receptor. We amplified and sequenced the V 2 16 receptor genes of various primates. Surprisingly, residue C195 is not conserved even among primates (Fig. 7B ). New and Old World monkeys have arginine and serine residues at this position, similar to other mammals. Residue C195 seems to have appeared roughly 20 to 30 million years ago, since the gibbons, diverging afterwards, already possess this residue.
We then asked how many of the class I GPCR's containing a conserved disulfide bond have an uneven number of extracellular cysteines, thus predisposing them to the formation of additional disulfide bonds by mutationally introduced cysteine residues. Among a total of 397 receptors only 18 such receptors (4.5%) were found (Fig. 8) , representing only 12 different receptors when species variants are ignored. The presence of an uneven number of extracellular cysteine residues is thus rare in this protein family.
DISCUSSION
It was previously demonstrated that residues G185 and R202 are not essential for V 2 receptor function (24) indicating that the defects of the NDI-causing mutants G185C and R202C are mediated by the introduced cysteine residues rather than by the residues replaced. The most obvious explanation for these findings was that the additional cysteine residues impair the formation of the conserved disulfide bond between residues C112 and C192. However, we
show here by second site C195A mutations that these residues instead seem to participate in a second disulfide bond with residue C195 of the V 2 receptor.
Another hint in the same direction came recently from studies with the tachykinin NK 1 receptor. Here, introduction of additional cysteine residues into the second extracellular loop did not affect the conserved disulfide bond and it was suggested that the same may apply to the cysteine-introducing, NDI-causing V 2 receptor mutations (25).
From our functional rescue data it appears obvious that two disulfide bonds are indeed formed in the NDI-causing mutant receptors, although we have not demonstrated directly that this second bond is formed between C195 and an additional cysteine residue. The possibility that two bonds are formed, each involving one of the conserved cysteine residues and either C195
or the mutationally introduced residue (e.g for the R202C mutant the combinations C112-C195 and C192-R202C or C192-C195 and C112-R202C) is, at first sight, also consistent with our functional rescue data. But this possibility is very unlikely when our previous results demonstrating that mutation of the conserved cysteine residues leads to a strong transport defect of the mutant receptors are taken into account (12) . Each of these alternative combinations would disrupt the conserved disulfide bond and should also cause a transport defect; however, this was not observed. Formation of a second disulfide bond between the 18 additional cysteine residues and C195 is also supported by our molecular modelling data. This bond would cause sealing of the entrance of the ligand binding cavity without having a strong influence on overall receptor folding, consistent with the binding defective but transport competent properties of these two mutant receptors (12) . The direct demonstration of the second disulfide bonds is nevertheless an important future goal and may be achieved e.g. by receptor isolation, proteolytic digestion and assignment of disulfide bond-connected fragments by mass spectrometry.
For the NDI-causing mutant receptors G185C and R202C, the additional C195A mutation led The mutations G185C and R202C are not unique in causing NDI by the introduction of additional cysteine residues. The mutations R106C, R181C and Y205C belong to the same family. Our structure model also allows predictions of the defects mediated by these mutations. The cysteine residue of mutant receptor R106C would lie at the same level in the molecule as those of the mutant receptors G185C and R202C and may also easily reach residue C195 (see Fig. 2A ). The functional properties of mutant receptor R106C have not been described as yet but formation of a second disulfide bond seems to be very likely in this 19 case. The same may be true for mutant receptor R181C. Although its extra cysteine residue would be located at a deeper level in the molecule it may also be close enough to C195 to form a second disulfide bond (see Fig. 2B ). Consistent with this, impaired ligand binding but preserved transport to the plasma membrane was described for this mutant receptor (5) . A binding defect was also described for mutant receptor Y205C (9) . In this case, a second disulfide bond may also be formed, although the introduced cysteine residue is located more distantly from C195.
Our databank analysis demonstrates that the presence of an uneven number of extracellular cysteine residues is rare within the class I family of GPCR's containing a conserved disulfide bond. We propose the existence of a strong selection pressure to avoid such a situation because these receptors are predisposed to inactivation by disulfide bond formation following the mutational introduction of extracellular cysteine residues. Interestingly, human rhodopsin was found among the receptors with an uneven number of extracellular cysteines. Here, the Y178C mutation was described as causing retinitis pigmentosa, and, similarly to the corresponding NDI-causing mutations of the V 2 receptor, it was proposed that the Y178C mutation impairs the formation of the conserved disulfide bond of rhodopsin (11) . Taking our results into account, the introduced cysteine residue may also form a second disulfide bond with the non-conserved, extracellular cysteine residue of rhodopsin. If so, additional mutation of the non-conserved cysteine residue should also suppress the defect of the Y178C mutation.
FOOTNOTES ¶ to whom correspondence should be adressed opsd_hum, human rhodopsin; opsd_bov, bovine rhodopsin; opsd_rat, rat rhodopsin; d4dr_mou, mouse D4 dopamine receptor; d4dr_rat, human D4 dopamine receptor; rgr_bov,.bovine RPE retinal G-protein coupled receptor; rgr_hum, human RPE retinal Gprotein coupled receptor; b1ar_mou, mouse beta-1 adrenergic receptor; b1ar_rat, rat beta-1 adrenergic receptor; hh2r_hum, human histamine 2 receptor; 5h2a_rat, human 5-hydroxytryptamine 2a receptor; rat 5h2b_rat, rat 5-hydroxytryptamine 2b receptor; 5h2c_hum, human 5-hydroxytryptamine 2c receptor; 5h5b_mou5, mouse 5-hydroxytryptamine 5b receptor; 5h5b_rat, rat 5-hydroxytryptamine 5b receptor; ssr1_hum, human somatostatin 1 receptor; grhr_pig, pig gonadotropin releasing hormone receptor.
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